OKYO Pharma (STU:OK10) FCF Margin %: 0.00% (As of Sep. 2025)


STU:OK10 OKYO Pharma Ltd STU:OK10
23 GF Score
Price €2.16
! 3 Warning Signs
View Full Analysis

What is OKYO Pharma FCF Margin %?

OKYO Pharma STU:OK10 23 FCF Margin % is 0.00% as of Sep. 2025. GuruFocus rates STU:OK10 with a GF Score™ of 23/100. The stock has 3 warning signs investors should review. Among 959 Biotechnology companies, OKYO Pharma ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. OKYO Pharma's Free Cash Flow for the six months ended in Sep. 2025 was €-1.30 Mil. OKYO Pharma's Revenue for the six months ended in Sep. 2025 was €0.00 Mil. Therefore, OKYO Pharma's FCF Margin % for the quarter that ended in Sep. 2025 was 0.00%.

As of today, OKYO Pharma's current FCF Yield % is -3.81%.

The historical rank and industry rank for OKYO Pharma's FCF Margin % or its related term are showing as below:


STU:OK10's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

OKYO Pharma FCF Margin % Related Terms

OKYO Pharma FCF Margin % Historical Data

* Premium members only.

The historical data trend for OKYO Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OKYO Pharma FCF Margin % Chart

OKYO Pharma Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OKYO Pharma Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

STU:OK10 vs SGMO, AARD, ANIX: FCF Margin % Comparison

For the Biotechnology subindustry, OKYO Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OKYO Pharma FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OKYO Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where OKYO Pharma's FCF Margin % falls into.


STU:OK10
23GF Score
OKYO Pharma Ltd STU:OK10
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OKYO Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

OKYO Pharma's FCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-1.676/0
= %

OKYO Pharma's FCF Margin for the quarter that ended in Sep. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=-1.302/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
OKYO Pharma (STU:OK10) has a FCF Margin % of 0.00% as of Sep. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on OKYO Pharma and its competitors. According to the industry distribution chart, OKYO Pharma ranks #999999 out of 959 companies in the Biotechnology industry.
Is OKYO Pharma's FCF Margin % too high?
OKYO Pharma's current FCF Margin % is 0.00%. Based on the distribution chart, OKYO Pharma ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, OKYO Pharma has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does OKYO Pharma's FCF Margin % compare to SGMO and AARD?
According to the Biotechnology industry distribution chart, OKYO Pharma ranks #999999 out of 959 companies for FCF Margin %. This places OKYO Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on OKYO Pharma and its competitors. OKYO Pharma's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OKYO Pharma stock overvalued right now?
OKYO Pharma (STU:OK10) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. OKYO Pharma's overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For OKYO Pharma (STU:OK10), the current FCF Margin % is 0.00% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OKYO Pharma Business Description

Other Exchanges OKYO:USA
Address 14/15 Conduit Street, Floor 4, London, GBR, W1S 2XJ
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
23GF Score

Get the complete analysis for STU:OK10

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.16
Price